Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis

Clin Exp Rheumatol. Nov-Dec 2005;23(6):916-7.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / adverse effects
  • Arthritis, Rheumatoid / drug therapy*
  • Cyclosporine / administration & dosage*
  • Cyclosporine / adverse effects
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infliximab
  • Male
  • Methotrexate / administration & dosage*
  • Methotrexate / adverse effects
  • Middle Aged

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Cyclosporine
  • Infliximab
  • Methotrexate